Login / Signup
Yu Gao
ORCID
Publication Activity (10 Years)
Years Active: 2020-2024
Publications (10 Years): 4
Top Topics
Ms Ms
Hyaluronic Acid
Cancer Stem Cells
Drug Release
Top Venues
Journal of liposome research
RSC advances
Pharmaceutical development and technology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yu Gao
,
Andrew N Shelling
,
Emma Nolan
,
David Porter
,
Euphemia Y Leung
,
Zimei Wu
Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells.
Journal of liposome research
(2024)
Yu Gao
,
Andrew N Shelling
,
Emma Nolan
,
David Porter
,
Euphemia Y Leung
,
Zimei Wu
Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells.
Journal of liposome research
34 (3) (2024)
Yu Gao
,
Andrew N Shelling
,
David Porter
,
Euphemia Y Leung
,
Zimei Wu
Stability of trastuzumab during nanomedicine formulation using SEC-HPLC coupled with polyacrylamide gel electrophoresis.
Pharmaceutical development and technology
(2023)
Yu Gao
,
Mingtan Tang
,
Euphemia Y Leung
,
Darren Svirskis
,
Andrew N Shelling
,
Zimei Wu
Dual or multiple drug loaded nanoparticles to target breast cancer stem cells.
RSC advances
10 (32) (2020)